Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.080 | Biomarker | disease | BEFREE | A microarray time course analysis of serial spheres passages from metastatic cells allowed us to specifically "profile" the NB stem cell-like phenotype and to identify CD133, ABC transporter, and WNT and NOTCH genes as spheres markers. | 22028624 | 2011 | ||||
|
0.080 | PosttranslationalModification | disease | BEFREE | Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines. | 20878131 | 2010 | ||||
|
0.080 | Biomarker | disease | BEFREE | In this study, we showed that the surface marker CD133 method was more suitable for isolating NB CSCs than the side-population method, and 60 µM etoposide was optimal for enriching NB CSCs. | 24789807 | 2014 | ||||
|
0.080 | Biomarker | disease | BEFREE | Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cells. | 21803487 | 2011 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | There was a significant association between CD133 expression and the following poor prognosis covariates: age, International Neuroblastoma Staging System stage, MYCN amplification, and phospho-AKT (pAKT) expression. | 22394107 | 2012 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | These abnormalities were found in NB samples and some were significantly correlated with CD133 expression. | 22514116 | 2012 | ||||
|
0.080 | Biomarker | disease | BEFREE | This study was performed to determine whether MYCN and CD133+ CSCs are associated with chemotherapy resistance and the survival time of patients with NB. | 29322842 | 2018 | ||||
|
0.080 | Biomarker | disease | BEFREE | Using side population (SP) cells as a marker for SLCC in human nasopharyngeal carcinoma (NPC) and CD133 for human neuroblastoma cells, we found that DNA damage inducers, UV and mitomycin C were capable of increasing SP cells in NPC CNE-2 and neuroblastoma SKN-SH cells. | 20007324 | 2010 |